Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$0.73 - $3.0 $21,692 - $89,148
29,716 Added 246.81%
41,756 $96,000
Q4 2023

Feb 14, 2024

BUY
$0.48 - $0.74 $5,779 - $8,909
12,040 New
12,040 $8,000
Q2 2022

Aug 16, 2022

SELL
$1.69 - $3.26 $25,380 - $48,958
-15,018 Closed
0 $0
Q1 2022

May 17, 2022

BUY
$2.99 - $4.19 $44,903 - $62,925
15,018 New
15,018 $47,000
Q1 2021

May 18, 2021

SELL
$5.03 - $10.5 $106,786 - $222,915
-21,230 Closed
0 $0
Q4 2020

Feb 17, 2021

BUY
$3.48 - $6.58 $73,880 - $139,693
21,230 New
21,230 $114,000

Others Institutions Holding EQ

About Equillium, Inc.


  • Ticker EQ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,352,100
  • Market Cap $47.1M
  • Description
  • Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...
More about EQ
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.